HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.

AbstractBACKGROUND:
Rates of contralateral prophylactic mastectomy (CPM) have increased in the United States, with younger women with breast cancer the most likely to have CPM.
METHODS:
As part of an ongoing cohort study of young women diagnosed with breast cancer at age ≤40 years, we conducted multinomial logistic regression of data from 560 women with unilateral Stage I-III disease to identify factors associated with: (1) CPM versus unilateral mastectomy (UM); (2) CPM versus breast-conserving surgery (BCS).
RESULTS:
Median age at diagnosis was 37 years; 66 % of women indicated that their doctor said that BCS was an option or was recommended. Of all women, 42.9 % had CPM, 26.8 % UM, and 30.4 % BCS. Among women who said the surgical decision was patient-driven, 59.9 % had CPM, 22.8 % BCS, and 17.3 % UM. Clinical characteristics associated with CPM versus BCS included HER2 positivity, nodal involvement, larger tumor size, lower BMI, parity, and testing positive for a BRCA mutation. Emotional and decisional factors associated with CPM versus UM and BCS included anxiety, less fear of recurrence, and reporting a patient-driven decision. Women who reported a physician-driven decision were less likely to have had CPM than both of the other surgeries, whereas higher confidence with the decision was associated with having CPM versus BCS.
CONCLUSIONS:
Many young women with early-stage breast cancer are choosing CPM. The association between CPM and emotional and decisional factors suggest that improved communication together with better psychosocial support may improve the decision-making process.
AuthorsShoshana M Rosenberg, Karen Sepucha, Kathryn J Ruddy, Rulla M Tamimi, Shari Gelber, Meghan E Meyer, Lidia Schapira, Steven E Come, Virginia F Borges, Mehra Golshan, Eric P Winer, Ann H Partridge
JournalAnnals of surgical oncology (Ann Surg Oncol) Vol. 22 Issue 12 Pg. 3809-15 (Nov 2015) ISSN: 1534-4681 [Electronic] United States
PMID25930247 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • ERBB2 protein, human
  • Receptor, ErbB-2
Topics
  • Adolescent
  • Adult
  • Anxiety (etiology)
  • Body Mass Index
  • Breast Neoplasms (genetics, pathology, prevention & control, surgery)
  • Decision Making
  • Directive Counseling
  • Fear
  • Female
  • Genes, BRCA1
  • Genes, BRCA2
  • Genetic Testing
  • Humans
  • Lymphatic Metastasis
  • Mastectomy, Segmental
  • Mutation
  • Neoplasm Staging
  • Parity
  • Patient Participation
  • Prophylactic Surgical Procedures (psychology)
  • Receptor, ErbB-2 (analysis)
  • Recurrence
  • Tumor Burden
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: